Cargando…
Diabetes increases mortality in patients with pancreatic and colorectal cancer by promoting cachexia and its associated inflammatory status
OBJECTIVES: Cancer is considered an emerging diabetes complication, with higher incidence and worse prognosis in patients with diabetes. Cancer is frequently associated with cachexia, a systemic metabolic disease causing wasting. It is currently unclear how diabetes affects the development and progr...
Autores principales: | Chovsepian, Alexandra, Prokopchuk, Olga, Petrova, Gabriela, Gjini, Tefta, Kuzi, Hanna, Heisz, Simone, Janssen, Klaus-Peter, Martignoni, Marc E., Friess, Helmut, Hauner, Hans, Rohm, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192649/ https://www.ncbi.nlm.nih.gov/pubmed/37094629 http://dx.doi.org/10.1016/j.molmet.2023.101729 |
Ejemplares similares
-
Specific miRNAs are associated with human cancer cachexia in an organ‐specific manner
por: Krauss, Tanja, et al.
Publicado: (2023) -
Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer
por: Prokopchuk, Olga, et al.
Publicado: (2018) -
Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia – can findings from animal models be translated to humans?
por: Mueller, Tara C., et al.
Publicado: (2016) -
A novel tissue inhibitor of metalloproteinases‐1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients
por: Prokopchuk, Olga, et al.
Publicado: (2021) -
Cancer cachexia
por: Martignoni, Marcus E, et al.
Publicado: (2003)